Poster Session Abstracts
P-VI - Pain Pharmacology
| GENDER-SPECIFIC EFFECTS OF LONG-TERM FLUOXETINE TREATMENT IN THE MOUSE FORMALIN TEST Zammataro M., Calabrese R., Sortino M., Chiechio S. |
| MMPIP, A MGLUR7 SELECTIVE NEGATIVE ALLOSTERIC MODULATOR, ALLEVIATES PAIN AND NORMALIZES AFFECTIVE AND COGNITIVE BEHAVIOUR IN NEUROPATHIC MICE Romano R., Palazzo E., Iannotta M., Gatta L., Luongo L., Bellini G., Rossi F., de Novellis V., Maione S. |
| ANTI-NOCICEPTIVE EFFECTS OF THE SELECTIVE CB2 AGONIST MT178 IN INFLAMMATORY AND CHRONIC RODENT PAIN MODELS Varani K., Vincenzi F., Targa M., Corciulo C., Gessi S., Merighi S., Saponaro G., Tabrizi M., Baraldi P., Borea P. |
| PARTHENOLIDE INHIBITS NOCICEPTION AND NEUROGENIC VASODILATATION IN THE TRIGEMINOVASCULAR SYSTEM BY TARGETING TRPA1 CHANNEL Materazzi S., Benemei S., Fusi C., Gualdani R., De Siena G., Vastani N., Ansersson D., Trevisan G., Moncelli M., Wei X., Dussor G., Pollastro F., Patacchini R., Appendino G., Geppetti P., Nassini R. |
| S-NITROSOGLUTATHIONE REDUCTASE (GSNOR) DEFICIENCY-INDUCED S-NITROSYLATION RESULTS INSPONTANEOUS PAIN RESPONSE Ilari S., Montagna C., Lauro F., Di Giacomo G., Rizza S., Cardaci S., Gliozzi M., Salvemini D., Filomeni G., Mollace V., Muscoli C. |
| ANTINOCICEPTIVE ACTIVITY OF THE PKR ANTAGONIST, PC1, BY DIFFERENT ROUTES OF ADMINISTRATION Marconi V., Lattanzi R., Maftei D., Giancotti L., Cappiello A., Balboni G., Negri L. |
| PROSTANOID SYSTEM IS INVOLVED IN BV8-INDUCED NOCICEPTION Giancotti L., Lattanzi R., Maftei D., Marconi V., Cappiello A., Vellani V., Sacerdote P., Negri L. |
| PROKINETICIN RECEPTOR ANTAGONISTS: PHARMACOLOGICAL CHARACTERIZATION Cappiello A., Marconi V., Lattanzi R., Maftei D., Giancotti L., Balboni G., Ambrosio C., Negri L. |
| PERIPHERAL NERVE INJURY INDUCED NEUROPATHY AND NEUROPATHIC PAIN: ROLE OF A NEW PLAYER Maftei D., Lattanzi R., Giancotti L., Marconi V., Cappiello A., Florenzano F., Negri L. |
| MODULATION OF PPARγ RECEPTORS REGULATES TOLERANCE TO MORPHINE ANALGESIA de Guglielmo G., Scuppa G., Kallupi M., Stopponi S., Ciccocioppo R. |
| EXEMESTANE, A STEROIDAL AROMATASE INHIBITOR, ACTIVATES THE TRPA1 CHANNEL ON SENSORY NEURONS CAUSING PAIN Fusi C., Nassini R., Benemei S., Minocci D., Geppetti P., Materazzi S. |
| ANTINOCICEPTIVE EFFECTS OF INNOVATIVE NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONISTS INFUSED BY INTRATHECAL ROUTE IN RATS Micheli L., Di Cesare Mannelli L., Zanardelli M., Cinci L., Baptista De Souza D., Rizzi A., Calò G., Guerrini R., Trapella C., Ghelardini C. |
| PKC-DEPENDENT ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE IN THE DEVELOPMENT OF HYPERALGESIA BY ULTRA-LOW DOSES OF MORPHINE Sanna M., Galeotti N., Ghelardini C. |
| PHARMACOKINETIC CHARACTERISTICS AND PHARMACOLOGICAL PROFILE OF POLYETHYLENGLICOLE DERIVATIVES OF PALMITOYLETHANOLAMIDE (PEA) Russo R., Avagliano C., Cristiano C., Orefice N., De Caro C., D'Agostino G., Mattace Raso G., Ostacolo C., La Rana G., Laneri S., Sacchi A., Meli R., Calignano A. |
| ANALGESIC PROPERTIES OF N-(1-CARBAMOYL-2-PHENYL-ETHYL) BUTYRAMIDE A NEW SYNTHETIC BUTYRATE PRODRUG IN A MODEL OF ACUTE AND VISCERAL PAIN. De Caro C., Avagliano C., Cristiano C., Orefice N., D'Agostino G., La Rana G., Mattace Raso G., Russo R., Berni Canani R., Meli R., Calignano A. |
| FUNCTIONAL AND MOLECULAR INTERPLAY BETWEEN PPARα RECEPTORS AND TRPV1 CHANNELS Soldovieri M., Ambrosino P., De Maria M., Di Sisto S., Marzilli E., Manocchio L., Taglialatela M. |
| NEUROPROTECTIVE EFFECTS OF THE α9α10 NACHR SELECTIVE ANTAGONIST (RGIA): A NEW POSSIBLE STRATEGY AGAINST NEUROPATHY Cinci L., Di Cesare Mannelli L., Micheli L., Zanardelli M., Pacini A., McIntosh J., Ghelardini C. |
| GLIA ROLE IN CHEMOTHERAPY-INDUCED NEUROPATHIC PAIN: A PHARMACOLOGICAL APPROACH Di Cesare Mannelli L., Micheli L., Zanardelli M., Cinci L., Baptista De Souza D., Pacini A., Ghelardini C. |
| PRECLINICAL EVALUATION OF WITHANIA SOMNIFERA’S EFFICACY: A NATURAL THERAPEUTIC PERSPECTIVE FOR PAIN RELIEF Orrù A., Marchese G., Casu G., Casu M., Manca G., Pilleri A., Ruiu S. |
| SALVINORIN A HAS ANTIINFLAMMATORY AND ANTINOCICEPTIVE EFFECTS MEDIATED BY KOR AND CB1 RECEPTORS De Chiaro M., Guida F., Luongo L., Boccella S., Aviello G., Borrelli F., Palazzo E., Gatta L., Zjawiony J., Scafuro M., Capasso R., de Novellis V., Izzo A., Maione S. |